Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TEM
TEMPUS AI, INC.
NASDAQ
$64.04
▼ DOWN 9.41% (-6.65)

KEY STATISTICS

Market Cap$11.22 B
52w High$104.32
52w Low$40.77
Dividend Yield—
Frequency—
P/E-128.08
Volume8.71M
Shares Out.175.20M

COMPANY

LEADERSHIP

Eric Lefkofsky
CHIEF EXECUTIVE
Eric Lefkofsky

COMPENSATION 2026

Salary$783,333
Stock Awards$39,992,500
Incentive Plan Pay$720,000
All Other Comp.$0
Total$41,495,833

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 14, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
3,800

PRICE TARGET

Target High$70.00
Target Low$50.00
Target Median$56.00
Target Consensus$59.40

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$409.90M
NOV
3
TUE

PRICE

$64.04 ▼ DOWN 9.41% (−$6.65)
$64.00$66.00$68.00$70.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM64.04

About Tempus AI, Inc.

https://www.tempus.com ↗

Tempus AI, Inc. is a Chicago-based healthcare tech company providing advanced molecular diagnostics, data insights, and clinical trial services to healthcare, pharma, and research organizations, with strategic collaborations in oncology.

INDUSTRY

Medical - Healthcare Information Services

A PRODUCT TEMPUS AI, INC. IS KNOWN FOR

HRD-RNA algorithm
HRD-RNA algorithm

An AI-powered 1,660-gene model offers real-time tumor HRD assessment to identify cancer patients likely to respond to treatments like platinum chemotherapy or PARP inhibitors.

COMPETITORS

COMPETITOR
FLGT COMPARE
GH COMPARE
MYGN COMPARE
NTRA COMPARE

Revenue by Products

IconPRODUCTQ1-2026Q2-2026
Diagnostics$261.1M $289.33M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
176
LISTED HERE
26
RANKED BY POSITION SIZE
ARKK
6.10% · 5.7M
VTI
0.01% · 3.6M
XMLD.DE
3.16% · 952.7K
IBB
0.50% · 789.4K
JTEK
1.11% · 726.4K
SCHM
0.13% · 284.9K
WTI2.DE
1.14% · 235.6K
ROBT
1.94% · 218.0K
THNQ
3.15% · 203.5K
AGIX
1.52% · 182.2K
FMDE
0.12% · 145.0K
QQQJ
0.59% · 101.6K
BBH
1.01% · 68.5K
NUSC
0.30% · 66.2K
IPO
2.30% · 49.2K
JHMM
0.05% · 43.1K
KOMP
0.09% · 33.7K
NANC
0.60% · 24.7K
HEAL
4.56% · 20.3K
BKMC
0.17% · 17.1K
DTEC
1.27% · 15.4K
NXTE
1.61% · 13.2K
PTL
0.07% · 9.2K
HELX
1.90% · 8.8K
BIB
0.39% · 6.2K
TILT
0.02% · 5.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
43.10%
HOLDERS
651
TOP 12 OF 651 · RANKED BY POSITION SIZE
Vanguard Group Inc
10.3M sh · $605.77M
Ark Investment Management LLC
10.0M sh · $580.61M
Baillie Gifford & Co
9.7M sh · $782.28M
Blackrock, Inc.
9.0M sh · $405.55M
Catalytic Wealth Ria, LLC
6.8M sh · $399.27M
Softbank Group Corp.
5.4M sh · $436.27M
Jpmorgan Chase & Co
5.0M sh · $291.22M
Nikko Asset Management Americas, Inc.
4.3M sh · $195.55M
Sumitomo Mitsui Trust Holdings, Inc.
4.3M sh · $195.64M
Goldman Sachs Group Inc
3.8M sh · $217.91M
Morgan Stanley
3.7M sh · $211.57M
Franklin Resources Inc
3.4M sh · $194.23M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Nancy Pelosi
Nancy Pelosi
Purchase
2026-01-16
 Rob Bresnahan
Rob Bresnahan
Purchase
2025-05-09

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CEO AND CHAIRMAN
LEFKOFSKY ERIC P
Sale · 9.3K shares
2026-08-25
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CEO AND CHAIRMAN
LEFKOFSKY ERIC P
Sale · 9.9K shares
2026-08-25
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CEO AND CHAIRMAN
LEFKOFSKY ERIC P
Sale · 24.2K shares
2026-08-25
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CEO AND CHAIRMAN
LEFKOFSKY ERIC P
Sale · 1.8K shares
2026-08-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
NEUTRAL 2
HOLD 1
OVERWEIGHT 1
10 GRADES IN THE LAST 12 MONTHS
BTIG BUY Piper Sandler NEUTRAL Stifel HOLD HC Wainwright & Co. BUY Needham BUY Guggenheim BUY TD Cowen BUY Morgan Stanley OVERWEIGHT

SECTORS PEERS

PEERPRICE
CNC$64.75COMPARE
MEDP$600.65COMPARE
NBIX$154.06COMPARE
COO$71.17COMPARE
ICLR$170.02COMPARE
FMS$23.10COMPARE
SNN$28.97COMPARE
UHS$171.66COMPARE